BioCatalystWatch
ABVXWorkspace / ABVX / OverviewCompany library
Price
Market cap
Next catalystExpected Q4 2026obefazimod (ABX464) · Study completionCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

obefazimod (ABX464)

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

obefazimod (ABX464)

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

obefazimod (ABX464)

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

obefazimod (ABX464)

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

obefazimod (ABX464)

Small molecule

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

Financial position

Cash and cash equivalents

Source and basis

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ABVX SEC archive